• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查的风险评估与临床决策

Risk assessment and clinical decision making for colorectal cancer screening.

作者信息

Schroy Paul C, Caron Sarah E, Sherman Bonnie J, Heeren Timothy C, Battaglia Tracy A

机构信息

Section of Gastroenterology, Boston University School of Medicine, Boston, MA, USA.

Women's Health Unit, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.

出版信息

Health Expect. 2015 Oct;18(5):1327-38. doi: 10.1111/hex.12110. Epub 2013 Jul 30.

DOI:10.1111/hex.12110
PMID:23905546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4213312/
Abstract

BACKGROUND

Shared decision making (SDM) related to test preference has been advocated as a potentially effective strategy for increasing adherence to colorectal cancer (CRC) screening, yet primary care providers (PCPs) are often reluctant to comply with patient preferences if they differ from their own. Risk stratification advanced colorectal neoplasia (ACN) provides a rational strategy for reconciling these differences.

OBJECTIVE

To assess the importance of risk stratification in PCP decision making related to test preference for average-risk patients and receptivity to use of an electronic risk assessment tool for ACN to facilitate SDM.

DESIGN

Mixed methods, including qualitative key informant interviews and a cross-sectional survey.

PARTICIPANTS

PCPs at an urban, academic safety-net institution.

MAIN MEASURES

Screening preferences, factors influencing patient recommendations and receptivity to use of a risk stratification tool.

KEY RESULTS

Nine PCPs participated in interviews and 57 completed the survey. Despite an overwhelming preference for colonoscopy by 95% of respondents, patient risk (67%) and patient preferences (63%) were more influential in their decision making than patient comorbidities (31%; P < 0.001). Age was the single most influential risk factor (excluding family history), with <20% of respondents choosing factors other than age. Most respondents reported that they would be likely to use a risk stratification tool in their practice either 'often' (43%) or sometimes (53%).

CONCLUSIONS

Risk stratification was perceived to be important in clinical decision making, yet few providers considered risk factors other than age for average-risk patients. Providers were receptive to the use of a risk assessment tool for ACN when recommending an appropriate screening test for select patients.

摘要

背景

与检查偏好相关的共同决策(SDM)被倡导为提高结直肠癌(CRC)筛查依从性的一种潜在有效策略,但如果患者偏好与初级保健提供者(PCP)自身的偏好不同,他们往往不愿意遵从。对晚期结直肠肿瘤(ACN)进行风险分层提供了一种协调这些差异的合理策略。

目的

评估风险分层在初级保健提供者针对平均风险患者的检查偏好决策中的重要性,以及对使用ACN电子风险评估工具以促进共同决策的接受程度。

设计

混合方法,包括定性关键信息访谈和横断面调查。

参与者

一家城市学术安全网机构的初级保健提供者。

主要测量指标

筛查偏好、影响患者推荐的因素以及对使用风险分层工具的接受程度。

关键结果

9名初级保健提供者参与了访谈,57人完成了调查。尽管95%的受访者压倒性地倾向于结肠镜检查,但患者风险(67%)和患者偏好(63%)在他们的决策中比患者合并症(31%;P<0.001)更具影响力。年龄是最具影响力的单一风险因素(不包括家族史),只有不到20%的受访者选择年龄以外的因素。大多数受访者表示,他们在实践中“经常”(43%)或“有时”(53%)可能会使用风险分层工具。

结论

风险分层在临床决策中被认为很重要,但很少有提供者考虑平均风险患者年龄以外的风险因素。在为特定患者推荐合适的筛查测试时,提供者愿意接受使用ACN风险评估工具。

相似文献

1
Risk assessment and clinical decision making for colorectal cancer screening.结直肠癌筛查的风险评估与临床决策
Health Expect. 2015 Oct;18(5):1327-38. doi: 10.1111/hex.12110. Epub 2013 Jul 30.
2
Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial.结直肠癌筛查的风险分层与共同决策:一项随机对照试验
Med Decis Making. 2016 May;36(4):526-35. doi: 10.1177/0272989X15625622. Epub 2016 Jan 19.
3
A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.筛查结肠镜检查时晚期结直肠肿瘤的风险预测指数
Am J Gastroenterol. 2015 Jul;110(7):1062-71. doi: 10.1038/ajg.2015.146. Epub 2015 May 26.
4
The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial.新型计算机决策辅助工具对结直肠癌筛查中共同决策的影响:一项随机试验。
Med Decis Making. 2011 Jan-Feb;31(1):93-107. doi: 10.1177/0272989X10369007. Epub 2010 May 18.
5
Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.辅助决策和结直肠癌筛查:一项随机对照试验。
Am J Prev Med. 2012 Dec;43(6):573-83. doi: 10.1016/j.amepre.2012.08.018.
6
Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making.提供者对结直肠癌筛查决策辅助工具在促进共享决策中的效用的看法。
Health Expect. 2014 Feb;17(1):27-35. doi: 10.1111/j.1369-7625.2011.00730.x. Epub 2011 Sep 8.
7
Primary Care Physicians' Support of Shared Decision Making for Different Cancer Screening Decisions.初级保健医生对不同癌症筛查决策中共同决策的支持。
Med Decis Making. 2017 Jan;37(1):70-78. doi: 10.1177/0272989X16660547. Epub 2016 Jul 18.
8
A risk prediction tool for colorectal cancer screening: a qualitative study of patient and provider facilitators and barriers.用于结直肠癌筛查的风险预测工具:患者和提供者促进和阻碍因素的定性研究。
BMC Fam Pract. 2020 Feb 26;21(1):43. doi: 10.1186/s12875-020-01113-0.
9
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.初级保健提供者和患者对肺癌筛查的看法。定性研究。
Ann Am Thorac Soc. 2016 Nov;13(11):1977-1982. doi: 10.1513/AnnalsATS.201604-286OC.
10
Engaging Women with Limited Health Literacy in Mammography Decision-Making: Perspectives of Patients and Primary Care Providers.参与健康素养有限的女性进行乳房 X 光检查决策:患者和初级保健提供者的观点。
J Gen Intern Med. 2021 Apr;36(4):938-945. doi: 10.1007/s11606-020-06213-2. Epub 2020 Sep 15.

引用本文的文献

1
The implementation challenge of computerised clinical decision support systems for the detection of disease in primary care: systematic review and recommendations.基层医疗中用于疾病检测的计算机化临床决策支持系统的实施挑战:系统评价与建议
Implement Sci. 2025 Jul 17;20(1):33. doi: 10.1186/s13012-025-01445-4.
2
Context factors in clinical decision-making: a scoping review.临床决策中的背景因素:一项范围综述
BMC Med Inform Decis Mak. 2025 Mar 17;25(1):133. doi: 10.1186/s12911-025-02965-1.
3
Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis.医疗保健专业人员和公众对基于个性化风险的癌症筛查的可接受性和认知:一项系统评价和荟萃分析。
Lancet Public Health. 2025 Feb;10(2):e85-e96. doi: 10.1016/S2468-2667(24)00278-0.
4
A scoping review of risk-stratified bowel screening: current evidence, future directions.风险分层肠道筛查的范围综述:当前证据,未来方向。
Cancer Causes Control. 2022 May;33(5):653-685. doi: 10.1007/s10552-022-01568-9. Epub 2022 Mar 20.
5
Gut microbiome identifies risk for colorectal polyps.肠道微生物群可识别结直肠息肉风险。
BMJ Open Gastroenterol. 2019 May 27;6(1):e000297. doi: 10.1136/bmjgast-2019-000297. eCollection 2019.
6
Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers.利用 HIV 风险预测工具确定暴露前预防的候选者:来自患者和初级保健提供者的观点。
AIDS Patient Care STDS. 2019 Aug;33(8):372-378. doi: 10.1089/apc.2019.0056. Epub 2019 Jun 17.
7
Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial.结直肠癌筛查的风险分层与共同决策:一项随机对照试验
Med Decis Making. 2016 May;36(4):526-35. doi: 10.1177/0272989X15625622. Epub 2016 Jan 19.
8
A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.筛查结肠镜检查时晚期结直肠肿瘤的风险预测指数
Am J Gastroenterol. 2015 Jul;110(7):1062-71. doi: 10.1038/ajg.2015.146. Epub 2015 May 26.

本文引用的文献

1
Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia.根据进展期近端腺瘤的风险来定制结直肠癌筛查。
Am J Med. 2012 Dec;125(12):1181-7. doi: 10.1016/j.amjmed.2012.05.026. Epub 2012 Oct 9.
2
Individualizing cancer screening in older adults: a narrative review and framework for future research.个体化老年人群癌症筛查:叙述性综述及未来研究框架
J Gen Intern Med. 2013 Feb;28(2):292-8. doi: 10.1007/s11606-012-2227-x. Epub 2012 Sep 28.
3
Contribution of screening and survival differences to racial disparities in colorectal cancer rates.筛查和生存差异对结直肠癌发病率的种族差异的影响。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):728-36. doi: 10.1158/1055-9965.EPI-12-0023. Epub 2012 Apr 18.
4
Patient-provider discussions about colorectal cancer screening: who initiates elements of informed decision making?医患关于结直肠癌筛查的讨论:谁主动开展知情决策的要素?
J Gen Intern Med. 2012 Sep;27(9):1135-41. doi: 10.1007/s11606-012-2045-1. Epub 2012 Apr 5.
5
Screening for colorectal cancer: a guidance statement from the American College of Physicians.结直肠癌筛查:美国医师学院的指南声明。
Ann Intern Med. 2012 Mar 6;156(5):378-86. doi: 10.7326/0003-4819-156-5-201203060-00010.
6
Cancer screening - United States, 2010.癌症筛查 - 美国,2010 年。
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):41-5.
7
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
8
Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice.在一个大型多专科初级保健实践中,对结直肠癌筛查测试和筛查测试使用的偏好。
Cancer. 2012 May 15;118(10):2726-34. doi: 10.1002/cncr.26551. Epub 2011 Sep 21.
9
Is it time to reassess colon cancer screening recommendations and acknowledge ethnic disparities?
Clin Gastroenterol Hepatol. 2011 Oct;9(10):859-61. doi: 10.1016/j.cgh.2011.05.029.
10
Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making.提供者对结直肠癌筛查决策辅助工具在促进共享决策中的效用的看法。
Health Expect. 2014 Feb;17(1):27-35. doi: 10.1111/j.1369-7625.2011.00730.x. Epub 2011 Sep 8.